| |
| |
|
| Insider
Information: |
Mclaughlin Gerald W. |
| Relationship: |
Director |
| City: |
Conshohocken |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
31,401 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$89,493 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,401 |
|
|
| Total
Value |
$89,493 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neos Therapeutics, Inc. |
NEOS |
Chief Executive Office... |
2021-03-19 |
0 |
2018-12-04 |
0 |
Premium* |
|
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-04-08 |
31,401 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2021-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
31,401 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2021-03-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,901 |
|
% |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-03-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(270,171) |
0 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-03-02 |
4 |
D |
$0.84 |
$37,414 |
D/D |
(44,329) |
270,171 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
290,000 |
314,500 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2018-12-06 |
4 |
B |
$2.11 |
$36,119 |
D/D |
17,097 |
24,500 |
2.81 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2018-12-04 |
4 |
B |
$2.04 |
$15,120 |
D/D |
7,403 |
7,403 |
2.81 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
